Genova Medical Retatrutide 40mg Pen is a pre-filled adjustable pen formulation containing 40mg of retatrutide.

According to the product packaging, retatrutide is described in relation to three metabolic hormone pathways:

• GLP-1
• GIP
• Glucagon

The box contains:

• 1 × adjustable dosage pen (40mg)
• 12 × disposable needles
• 1 × user manual

Retatrutide is investigated in scientific research involving metabolic signalling, energy regulation, appetite-related pathways, and body-composition research.

Key Features

• Genova Medical Retatrutide 40mg
• 40mg pre-filled pen
• Adjustable dosage pen format
• GLP-1, GIP & glucagon pathway activity
• 12 disposable needles included
• User manual included
• Designed for controlled research applications

How to Use (Research Reference Only)

This product is intended exclusively for laboratory and scientific research conducted by qualified professionals following established research protocols.

No human-use dosing or administration instructions are provided.

Not intended for human consumption.

Research Applications

Retatrutide may be investigated in laboratory research involving:

• GLP-1 receptor signalling
• GIP receptor signalling
• Glucagon receptor pathways
• Metabolic regulation
• Energy-balance research
• Appetite-related signalling
• Body-composition studies

Research Disclaimer

For laboratory and scientific research use only.

Not intended for human consumption, therapeutic use, diagnosis, or medical application.

What is Retatrutide?

Retatrutide is a multi-pathway peptide being investigated for its activity across GLP-1, GIP, and glucagon signalling. Research focuses on its potential effects on metabolic pathways, energy regulation, appetite-related signalling, and body-composition models.